Literature DB >> 11606769

Reactivation of proliferin gene expression is associated with increased angiogenesis in a cell culture model of fibrosarcoma tumor progression.

D J Toft1, S B Rosenberg, G Bergers, O Volpert, D I Linzer.   

Abstract

Proliferin (PLF) is an angiogenic placental hormone. We now report that PLF gene expression can also occur in a progressive fibrosarcoma mouse tumor cell model. PLF mRNA and protein are detectable at very low levels in cell lines derived from the mild noninvasive stage of tumor development. Expression is greatly augmented in cell lines from the aggressively invasive stage of development, a stage at which the tumor becomes highly angiogenic, and PLF expression remains high in cell lines from the end stage of fibrosarcoma. Activator protein 1 factors present at high levels in the more invasive stages of the tumor may in part allow for increased PLF expression, as cells from the mild stage in which c-jun and junB are stably expressed secrete levels of PLF comparable to that of the advanced stages. Secreted PLF protein is functionally important in tumor cell angiogenic activity, as demonstrated by the reduction of angiogenic activity in fibrosarcoma cell culture medium by immunodepletion of PLF. These results suggest that an extraembryonic genetic program, which has evolved to support fetal growth, may be reactivated in certain tumors and contribute to tumor growth.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11606769      PMCID: PMC60823          DOI: 10.1073/pnas.231364798

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Induction of megakaryocyte differentiation by a novel pregnancy-specific hormone.

Authors:  J Lin; D I Linzer
Journal:  J Biol Chem       Date:  1999-07-23       Impact factor: 5.157

Review 2.  Placental prolactins and the physiology of pregnancy.

Authors:  J Lin; D J Toft; N W Bengtson; D I Linzer
Journal:  Recent Prog Horm Res       Date:  2000

3.  Mrp3, a mitogen-regulated protein/proliferin gene expressed in wound healing and in hair follicles.

Authors:  J T Fassett; M Nilsen-Hamilton
Journal:  Endocrinology       Date:  2001-05       Impact factor: 4.736

4.  Expression of multiple proliferin genes in mouse cells.

Authors:  E L Wilder; D I Linzer
Journal:  Mol Cell Biol       Date:  1986-09       Impact factor: 4.272

5.  Nucleotide sequence of a growth-related mRNA encoding a member of the prolactin-growth hormone family.

Authors:  D I Linzer; D Nathans
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

6.  Signaling between the placenta and the uterus involving the mitogen-regulated protein/proliferins.

Authors:  Y Fang; P Lepont; J T Fassett; S P Ford; A Mubaidin; R T Hamilton; M Nilsen-Hamilton
Journal:  Endocrinology       Date:  1999-11       Impact factor: 4.736

7.  Selective stimulation by mitogens of incorporation of 35S-methionine into a family of proteins released into the medium by 3T3 cells.

Authors:  M Nilsen-Hamilton; J M Shapiro; S L Massoglia; R T Hamilton
Journal:  Cell       Date:  1980-05       Impact factor: 41.582

8.  Bovine papillomavirus genome elicits skin tumours in transgenic mice.

Authors:  M Lacey; S Alpert; D Hanahan
Journal:  Nature       Date:  1986 Aug 14-20       Impact factor: 49.962

9.  Relationship between mitogen-regulated protein (MRP) and proliferin (PLF), a member of the prolactin/growth hormone family.

Authors:  M Nilsen-Hamilton; R T Hamilton; E Alvarez-Azaustre
Journal:  Gene       Date:  1987       Impact factor: 3.688

10.  Identification of proliferin mRNA and protein in mouse placenta.

Authors:  D I Linzer; S J Lee; L Ogren; F Talamantes; D Nathans
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

View more
  31 in total

Review 1.  Emerging roles of ATF2 and the dynamic AP1 network in cancer.

Authors:  Pablo Lopez-Bergami; Eric Lau; Ze'ev Ronai
Journal:  Nat Rev Cancer       Date:  2010-01       Impact factor: 60.716

2.  The rat prolactin gene family locus: species-specific gene family expansion.

Authors:  S M Khorshed Alam; Rupasri Ain; Toshihiro Konno; Jennifer K Ho-Chen; Michael J Soares
Journal:  Mamm Genome       Date:  2006-08-04       Impact factor: 2.957

3.  Role of Msi1 and MAML1 in Regulation of Notch Signaling Pathway in Patients with Esophageal Squamous Cell Carcinoma.

Authors:  Meysam Moghbeli; Mohammad Mahdi Forghanifard; Ali Sadrizadeh; Hooman Mosannen Mozaffari; Ebrahim Golmakani; Mohammad Reza Abbaszadegan
Journal:  J Gastrointest Cancer       Date:  2015-12

4.  The Bromodomain BET Inhibitor JQ1 Suppresses Tumor Angiogenesis in Models of Childhood Sarcoma.

Authors:  Hemant K Bid; Doris A Phelps; Linlin Xaio; Denis C Guttridge; Jiayuh Lin; Cheryl London; Laurence H Baker; Xiaokui Mo; Peter J Houghton
Journal:  Mol Cancer Ther       Date:  2016-02-23       Impact factor: 6.261

5.  Bridging sequence diversity and tissue-specific expression by DNA methylation in genes of the mouse prolactin superfamily.

Authors:  Koji Hayakawa; Momo O Nakanishi; Jun Ohgane; Satoshi Tanaka; Mitsuko Hirosawa; Michael J Soares; Shintaro Yagi; Kunio Shiota
Journal:  Mamm Genome       Date:  2011-12-23       Impact factor: 2.957

6.  Angiogenesis induced by signal transducer and activator of transcription 5A (STAT5A) is dependent on autocrine activity of proliferin.

Authors:  Xinhai Yang; Dianhua Qiao; Kristy Meyer; Thomas Pier; Sunduz Keles; Andreas Friedl
Journal:  J Biol Chem       Date:  2011-12-23       Impact factor: 5.157

7.  IKKalpha, IKKbeta, and NEMO/IKKgamma are each required for the NF-kappa B-mediated inflammatory response program.

Authors:  Xiang Li; Paul E Massa; Adedayo Hanidu; Gregory W Peet; Patrick Aro; Ann Savitt; Sheenah Mische; Jun Li; Kenneth B Marcu
Journal:  J Biol Chem       Date:  2002-09-06       Impact factor: 5.157

8.  Multiple kinase cascades mediate prolactin signals to activating protein-1 in breast cancer cells.

Authors:  Jennifer H Gutzman; Debra E Rugowski; Matthew D Schroeder; Jyoti J Watters; Linda A Schuler
Journal:  Mol Endocrinol       Date:  2004-08-19

9.  Musashi1 modulates mammary progenitor cell expansion through proliferin-mediated activation of the Wnt and Notch pathways.

Authors:  Xiao-Yang Wang; Yuzhi Yin; Hongyan Yuan; Toshiyuki Sakamaki; Hideyuki Okano; Robert I Glazer
Journal:  Mol Cell Biol       Date:  2008-03-24       Impact factor: 4.272

10.  Suppression of acetylpolyamine oxidase by selected AP-1 members regulates DNp73 abundance: mechanistic insights for overcoming DNp73-mediated resistance to chemotherapeutic drugs.

Authors:  W Bunjobpol; I Dulloo; K Igarashi; N Concin; K Matsuo; K Sabapathy
Journal:  Cell Death Differ       Date:  2014-04-11       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.